<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03384667</url>
  </required_header>
  <id_info>
    <org_study_id>ISEE_MMDT_2017</org_study_id>
    <nct_id>NCT03384667</nct_id>
  </id_info>
  <brief_title>Maekmoondong-tang on Post-operative Cough in Patients With Lung Cancer</brief_title>
  <official_title>Efficacy and Safety Evaluation of Maekmoondong-tang on Post-operative Cough in Patients With Lung Cancer -Randomized, Double-blind, Placebo-controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seong-Gyu Ko</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kyunghee University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to evaluate the efficacy and safety of Maekmoondong-tang on
      post-operative cough in patients with lung cancer. A randomized, double-blind,
      placebo-controlled trial will be conducted.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 22, 2018</start_date>
  <completion_date type="Anticipated">March 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A randomized, double-blind, placebo-controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Leicester Cough Questionnaire (LCQ)</measure>
    <time_frame>Day 0 to Day 28</time_frame>
    <description>Questionnaire used to measure quality of life in cough patients. The total score of LCQ is 3 to 21, and a higher score means a better quality of life.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cough VAS</measure>
    <time_frame>Day 0 to Day 28</time_frame>
    <description>Measure frequency and severity of cough by VAS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Yin deficiency scale</measure>
    <time_frame>Day 0 to Day 28</time_frame>
    <description>Questionnaire measures yin deficiency</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Postoperative Cough</condition>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>MMDT group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Maekmoondong-tang</intervention_name>
    <description>MMDT is a Herbal medicine consist of six herbs.</description>
    <arm_group_label>MMDT group</arm_group_label>
    <other_name>Maekgeuron Granules</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>The granules do not contain any active ingredients.</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults over 20 years old.

          -  Patients undergone segmentectomy or lobectomy for lung cancer within 1 month

          -  Patients who do not or poorly respond to one week administration of common antitussive
             agents.

          -  Eastern Cooperative Oncology Group(ECOG) 0 to 2

          -  Participant is willing and able to give informed consent for participation in the
             study

        Exclusion Criteria:

          -  Patients undergoing adjuvant chemotherapy.

          -  Patients who have been diagnosed with acute respiratory disease within 1 month.

          -  Patients who have been diagnosed with bronchial asthma or bronchiectasis within 1 year

          -  Patients taking Angiotensin Converting Enzyme Inhibitor

          -  Patients with pseudoaldosteronism.

          -  Participants who have known prior hypersensitivity to any investigational product
             component

          -  Patient with acute or chronic infections requiring treatment (active HAV, HBV, HCV,
             HIV, TB)

          -  Pregnant or lactating females

          -  Women of childbearing potential

          -  Patient who do not agrees to use effective means of contraception and not to donate
             sperm during the trial and up to 1 month after final administration

          -  Patient who participated other clinical trials of medicine or medical devices within 1
             month

          -  Individuals who are judged inappropriate for the study by investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chunhoo Cheon, Dr.</last_name>
    <phone>8229619278</phone>
    <email>hreedom35@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Korea University Guro Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>130-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyojin Son</last_name>
      <phone>82-2-2626-1185</phone>
      <email>crisphj@naver.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2017</study_first_submitted>
  <study_first_submitted_qc>December 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 27, 2017</study_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Kyunghee University Medical Center</investigator_affiliation>
    <investigator_full_name>Seong-Gyu Ko</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <keyword>Maekmoondong-tang</keyword>
  <keyword>Mai-men-dong-tang</keyword>
  <keyword>Bakumondo-to</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Cough</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

